To improve these features, Niu and colleagues developed a delivery system composed of PEGylated G5 PAMAM dendrimers and an EpCAM aptamer to target moiety to deliver celastrol (Apt-Ce-PAMAM) to colorectal cancer cells. This evidence concerns the gene EPCAM and colorectal cancer.